117 related articles for article (PubMed ID: 23898439)
1. Treatment of diabetic foot ulcer using matriderm in comparison with a skin graft.
Jeon H; Kim J; Yeo H; Jeong H; Son D; Han K
Arch Plast Surg; 2013 Jul; 40(4):403-8. PubMed ID: 23898439
[TBL] [Abstract][Full Text] [Related]
2. The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report.
Cervelli V; Lucarini L; Cerretani C; Spallone D; Palla L; Brinci L; De Angelis B
Int Wound J; 2010 Aug; 7(4):291-6. PubMed ID: 20529143
[TBL] [Abstract][Full Text] [Related]
3. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
4. The use of MatriDerm® and skin grafting in post-traumatic wounds.
Cervelli V; Brinci L; Spallone D; Tati E; Palla L; Lucarini L; De Angelis B
Int Wound J; 2011 Aug; 8(4):400-5. PubMed ID: 21564554
[TBL] [Abstract][Full Text] [Related]
5. The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns--a pilot study.
Ryssel H; Gazyakan E; Germann G; Ohlbauer M
Burns; 2008 Feb; 34(1):93-7. PubMed ID: 17644263
[TBL] [Abstract][Full Text] [Related]
6. The use of matriderm and autologous skin graft in the treatment of full thickness skin defects.
Min JH; Yun IS; Lew DH; Roh TS; Lee WJ
Arch Plast Surg; 2014 Jul; 41(4):330-6. PubMed ID: 25075353
[TBL] [Abstract][Full Text] [Related]
7. The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers.
Buchberger B; Follmann M; Freyer D; Huppertz H; Ehm A; Wasem J
GMS Health Technol Assess; 2010 Sep; 6():Doc12. PubMed ID: 21289885
[TBL] [Abstract][Full Text] [Related]
8. Coverage of radial forearm flap donor site with full thickness skin graft and Matriderm®: An alternative reliable solution?
Cristofari S; Guenane Y; Atlan M; Hallier A; Revol M; Stivala A
Ann Chir Plast Esthet; 2020 Jun; 65(3):213-218. PubMed ID: 31445777
[TBL] [Abstract][Full Text] [Related]
9. DERMAL REPLACEMENT WITH MATRIDERM - FIRST EXPERIENCE AT THE PRAGUE BURN CENTRE.
Zajíček R; Šuca H; Grossová I; Fetissov V; Pafčuga I
Acta Chir Plast; 2020; 62(3-4):79-82. PubMed ID: 33685201
[TBL] [Abstract][Full Text] [Related]
10. The effects of topical anesthesia on outcomes and glucose control in diabetic patients treated with split-thickness skin graft surgery.
Chang DH; Lin SC; Lin YT; Chang KC; Chan CL
J Chin Med Assoc; 2023 Mar; 86(3):306-312. PubMed ID: 36527190
[TBL] [Abstract][Full Text] [Related]
11. Matriderm dermal substitute in the treatment of post traumatic hand's fingertip tissue loss.
Fulchignoni C; Rocchi L; Cauteruccio M; Merendi G
J Cosmet Dermatol; 2022 Feb; 21(2):750-757. PubMed ID: 33786967
[TBL] [Abstract][Full Text] [Related]
12. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage.
Puttirutvong P
J Med Assoc Thai; 2004 Jan; 87(1):66-72. PubMed ID: 14971537
[TBL] [Abstract][Full Text] [Related]
13. Split thickness skin grafts for the treatment of non-healing foot and leg ulcers in patients with diabetes: a retrospective review.
Anderson JJ; Wallin KJ; Spencer L
Diabet Foot Ankle; 2012; 3():. PubMed ID: 22403742
[TBL] [Abstract][Full Text] [Related]
14. [Dermal subsitute with the collagen-elastin matrix Matriderm in burn injuries: a comprehensive review].
Kolokythas P; Aust MC; Vogt PM; Paulsen F
Handchir Mikrochir Plast Chir; 2008 Dec; 40(6):367-71. PubMed ID: 18629763
[TBL] [Abstract][Full Text] [Related]
15. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
16. Healing hard-to-heal diabetic foot ulcers: the role of dehydrated amniotic allograft with cross-linked bovine-tendon collagen and glycosaminoglycan matrix.
Tsai GL; Zilberbrand D; Liao WJ; Horl LP
J Wound Care; 2021 Jul; 30(Sup7):S47-S53. PubMed ID: 34256586
[TBL] [Abstract][Full Text] [Related]
17. Split-skin graft in the management of diabetic foot ulcers.
Mahmoud SM; Mohamed AA; Mahdi SE; Ahmed ME
J Wound Care; 2008 Jul; 17(7):303-6. PubMed ID: 18705232
[TBL] [Abstract][Full Text] [Related]
18. Management of defects on lower extremities with the use of matriderm and skin graft.
Choi JY; Kim SH; Oh GJ; Roh SG; Lee NH; Yang KM
Arch Plast Surg; 2014 Jul; 41(4):337-43. PubMed ID: 25075354
[TBL] [Abstract][Full Text] [Related]
19. Failure rates of artificial dermis products in treatment of diabetic foot ulcer: A systematic review and network meta-analysis.
Tchero H; Herlin C; Bekara F; Kangambega P; Sergiu F; Teot L
Wound Repair Regen; 2017 Aug; 25(4):691-696. PubMed ID: 28597935
[TBL] [Abstract][Full Text] [Related]
20. The effects of cross-linking a collagen-elastin dermal template on scaffold bio-stability and degradation.
Maitz J; Wang Y; Fathi A; Ximena Escobar F; Parungao R; van Zuijlen P; Maitz P; Li Z
J Tissue Eng Regen Med; 2020 Sep; 14(9):1189-1200. PubMed ID: 32721107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
